Clinical Trial Update: Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of bosentan for progressive pulmonary sarcoidosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sarcoidosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Daniel Doberer | Conditions: Sarcoidosis, Pulmonary Hypertension | Phase 2 | Status: TERMINATED